How to bring academic research and the industry closer together

By: Mira Halvorsen Børstad | 11. jan. 2019 | News, Diatec stories
Group picture of Gerbrand Koster, Jan Terje Andersen, Simone Mester, Bjørn Pedersen and Mira Børstad
From the left: Gerbrand Koster (Inven2), Jan Terje Andersen (OUS/UIO), Simone Mester (OUS/UIO), Bjørn Pedersen (Diatec Monoclonals) and Mira Børstad (Diatec Monoclonals).

Diatec Monoclonals is proud to announce that our Managing Director, Bjørn Pedersen will mentor Simone Mester’s SPARK-Norway project. SPARK Norway is the University of Oslo’s innovation program, supported by Inven2, and aims to develop ideas within health related topics in the life science domain. Simone Mester is designing new antibody formats with extended half-life that target cancer. She is part of Jan Terje Andersen’s research group at the University of Oslo and Oslo University Hospital. You can read more about the SPARK program at and the research of Jan Terje Andersen and his group at